NasdaqGS:BRKRLife Sciences
Bruker (BRKR) Stock May Be 28% Undervalued On Cash Flow Views
Bruker stock is coming off a strong year, with the share price up 43.3% over the past 12 months, while both market multiples and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach currently point to the shares trading below that intrinsic value.
Over the past year, Bruker has returned 43.3%, which puts more focus on whether the current price still leaves a margin between market value and intrinsic value.
For a science and instrumentation business like Bruker,...